AT243987B - Verfahren zur Herstellung eines Impfstoffes zur gleichzeitigen Immunisierung von Hunden oder Füchsen gegen Staupe, Hepatitis contagiosa canis und Leptospirose - Google Patents

Verfahren zur Herstellung eines Impfstoffes zur gleichzeitigen Immunisierung von Hunden oder Füchsen gegen Staupe, Hepatitis contagiosa canis und Leptospirose

Info

Publication number
AT243987B
AT243987B AT553063A AT553063A AT243987B AT 243987 B AT243987 B AT 243987B AT 553063 A AT553063 A AT 553063A AT 553063 A AT553063 A AT 553063A AT 243987 B AT243987 B AT 243987B
Authority
AT
Austria
Prior art keywords
leptospirosis
vaccine
dogs
production
simultaneous immunization
Prior art date
Application number
AT553063A
Other languages
German (de)
English (en)
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Application granted granted Critical
Publication of AT243987B publication Critical patent/AT243987B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT553063A 1962-07-12 1963-07-10 Verfahren zur Herstellung eines Impfstoffes zur gleichzeitigen Immunisierung von Hunden oder Füchsen gegen Staupe, Hepatitis contagiosa canis und Leptospirose AT243987B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB68006A DE1283438B (de) 1962-07-12 1962-07-12 Verfahren zur Herstellung eines Impfstoffes zur gleichzeitigen Immunisierung von Hunden oder Fuechsen gegen Staupe, Hepatitis contagiosa canis und Leptospirose

Publications (1)

Publication Number Publication Date
AT243987B true AT243987B (de) 1965-12-10

Family

ID=6975728

Family Applications (1)

Application Number Title Priority Date Filing Date
AT553063A AT243987B (de) 1962-07-12 1963-07-10 Verfahren zur Herstellung eines Impfstoffes zur gleichzeitigen Immunisierung von Hunden oder Füchsen gegen Staupe, Hepatitis contagiosa canis und Leptospirose

Country Status (8)

Country Link
AT (1) AT243987B (en:Method)
CA (1) CA937864A (en:Method)
DE (1) DE1283438B (en:Method)
FI (1) FI40561B (en:Method)
GB (1) GB1008078A (en:Method)
LU (1) LU43999A1 (en:Method)
NL (2) NL145902B (en:Method)
SE (1) SE308574B (en:Method)

Also Published As

Publication number Publication date
CA937864A (en) 1973-12-04
LU43999A1 (en:Method) 1963-09-03
NL295135A (en:Method)
FI40561B (en:Method) 1968-11-30
DE1283438B (de) 1968-11-21
GB1008078A (en) 1965-10-27
NL145902B (nl) 1975-05-15
SE308574B (en:Method) 1969-02-17

Similar Documents

Publication Publication Date Title
CH439747A (de) Verfahren zur Herstellung von Fluor enthaltenden Polymerisaten
CH441286A (de) Verfahren zur Herstellung von Alkenderivaten
AT242957B (de) Verfahren zur Herstellung von härtbaren, modifizierten Harzen
CH439290A (de) Verfahren zur Herstellung von 4-Amino-6,7-dialkoxychinolinen
CH456549A (de) Verfahren zur Herstellung eines Katalysators
AT240362B (de) Verfahren zur Herstellung von Carbonsäureamiden
AT242294B (de) Verfahren zur Herstellung von Masernvaccin
CH469093A (de) Verfahren zur Herstellung eines neuen Impfstoffes gegen Panleucopenia
CH457385A (de) Verfahren zur Herstellung von Persäuren
AT243987B (de) Verfahren zur Herstellung eines Impfstoffes zur gleichzeitigen Immunisierung von Hunden oder Füchsen gegen Staupe, Hepatitis contagiosa canis und Leptospirose
CH455768A (de) Verfahren zur Herstellung von Pyridinen
CH439749A (de) Verfahren zur Herstellung von wässrigem Copolymer-Latex
CH437352A (de) Verfahren zur Herstellung von Aminophenolen
CH394215A (de) Verfahren zur Herstellung von Aminoketonderivaten
AT336779B (de) Verfahren zur herstellung einer intravenos vertraglichen vaccine gegen staupe und hepatitis contagiosa canis
CH444136A (de) Verfahren zur Herstellung von Dicarbonsäuredialkylestern
AT243794B (de) Verfahren zur Herstellung von Carbostyrilderivaten
AT279038B (de) Verfahren zur Herstellung eines Impfstoffes gegen Röteln
AT259527B (de) Verfahren zur Herstellung von Dispersionen
AT238702B (de) Verfahren zur Herstellung von 1-Acetoxy-1,1-dicyanoäthan
CH460036A (de) Verfahren zur Herstellung von Morphinan-Derivaten
CH375339A (de) Verfahren zur Herstellung von Benzolsulfonylharnstoffen
AT248427B (de) Verfahren zur Herstellung von 3-Amino-2-oxazolidon-hydrochlorid
CH416653A (de) Verfahren zur Herstellung von 2-Methyl-3-o-äthylphenyl-4-oxo-3,4-dihydro-chinazolin
CH439282A (de) Verfahren zur Herstellung von 11-Keto-5a,9B,10a-19-nor-steroiden